<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Best evidence statement (BESt). Screening and management of dyslipidemia in diabetic patients.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Cincinnati Children's Hospital Medical Center. Best evidence statement (BESt). Screening and management of dyslipidemia in diabetic patients. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2010 Oct 27. 6 p.  [8 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Diabetes with other coma, type I [juvenile type], not stated as uncontrolled  (250.31); Unspecified disorder of lipoid metabolism  (272.9)"/><FieldValue Value="MSH: Diabetes Mellitus ; Diabetes Mellitus, Type 1 ; Diet, Fat-Restricted ; Dyslipidemias ; Exercise ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Lipid Metabolism Disorders ; Medical History Taking ; Phytosterols ; Referral and Consultation "/><FieldValue Value="MTH: Diabetes Mellitus ; Diabetes Mellitus, Insulin-Dependent ; Exercise ; Fat-Restricted Diet ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Lipid Metabolism Disorders ; Plasma fasting LDL cholesterol measurement ; Serum fasting LDL cholesterol measurement "/><FieldValue Value="SNOMEDCT_US: Diabetes mellitus  (73211009); Diet good  (226234005); Diet good  (310500000); Disorder of lipid metabolism  (267431006); Dyslipidemia  (370992007); Exercise  (183301007); Exercise  (256235009); Exercise  (61686008); f - Family history  (277652007); HMG-CoA reductase inhibitor  (372912004); HMG-CoA reductase inhibitor  (96302009); Low fat diet  (16208003); Low fat diet  (436861000124104); Phytosterol  (226360008); Plasma fasting LDL cholesterol measurement  (167075004); Serum fasting LDL cholesterol measurement  (166840006); Type 1 diabetes mellitus  (46635009)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Dyslipidemia &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Diabetes &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Management" /><FieldValue Value="Screening" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Cardiology" /><FieldValue Value="Endocrinology" /><FieldValue Value="Family Practice" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Pediatrics" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Nurses" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To evaluate what is the optimal screening for dyslipidemia to reduce risk of cardiovascular complications in pediatric patients with diabetes&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Pediatric patients with diabetes&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Screening&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Fasting low-density lipoprotein (LDL) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of family history of cardiovascular disease, age, and puberty &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Management/Treatment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Heart healthy diet &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Exercise &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Monitor low-density lipoprotein (LDL) levels &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Inclusion of plant sterols in diet &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Statins &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Referral to cardiology &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Risk of cardiovascular complications &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Low-density lipoprotein (LDL) levels &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Search Strategy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Initial search&lt;/strong&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;DATABASE: Ovid: MedLine &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;OVID FILTERS&#xD;&#xA;        &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Publication dates: 1996 to May 21, 2010 &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Limits: English language &lt;br /&gt;&#xD;&#xA;            all child (0 to 18 years) &lt;/li&gt;&#xD;&#xA;        &lt;/ul&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;SEARCH TERMS &amp;amp; MeSH TERMS&#xD;&#xA;        &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;            &lt;li&gt;exp *Diabetes Mellitus/AND exp Dyslipidemias/&#xD;&#xA;            &lt;p&gt;search results filtered for: diagnosis subheading OR treatment outcome.mp.&lt;/p&gt;&#xD;&#xA;            &lt;/li&gt;&#xD;&#xA;        &lt;/ul&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;2&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Search for synthesized evidence&lt;/strong&gt;&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;DATABASE: Ovid: MedLine &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;OVID FILTERS&#xD;&#xA;        &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;            &lt;li&gt;Publication dates: 1996 to Mar 3, 2010 &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Limits: English language &lt;br /&gt;&#xD;&#xA;            all child (0 to 18 years) &lt;/li&gt;&#xD;&#xA;            &lt;li&gt;Publication type: (guideline or meta analysis or practice guidelines or systematic review).pt. or &quot;the cochrane library&quot;.jn. or &quot;cochrane database of systematic reviews&quot;.jn. &lt;/li&gt;&#xD;&#xA;        &lt;/ul&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;SEARCH TERMS &amp;amp; MeSH TERMS&#xD;&#xA;        &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;            &lt;li&gt;exp Diabetes Mellitus/ or Diabetes Mellitus, Experimental/ or Diabetes, Gestational/ or Diabetes Insipidus, Neurogenic/ or Diabetes Complications/ or Diabetes Insipidus, Nephrogenic/ or Diabetes Mellitus, Lipoatrophic/ or &quot;National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)&quot;/ or Diabetes Insipidus/ &lt;/li&gt;&#xD;&#xA;        &lt;/ul&gt;&#xD;&#xA;        &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Table of Evidence Levels&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Table of Evidence Levels&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Quality Level&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;1a&amp;dagger; or 1b&amp;dagger;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Systematic review, meta-analysis, or meta-synthesis of multiple studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;2a or 2b&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Best study design for domain&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;3a or 3b&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Fair study design for domain&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;4a or 4b&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Weak study design for domain&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;5&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Other: General review, expert opinion, case report, consensus report, or guideline&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&amp;dagger;a = good quality study; b = lesser quality study&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Systematic Review with Evidence Tables" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The literature search identified three main guidelines:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The American Heart Association (AHA) Scientific Statement that addresses Cardiovascular Risk Reduction in High-Risk Pediatric Patients &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A Statement from the American Diabetes Association (ADA) regarding the Care of Children and Adolescents with Type 1 Diabetes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The American Academy of Pediatrics (AAP) reporting on Lipid Screening and Cardiovascular Health in Childhood &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;These guidelines were appraised using the AGREE (Appraisal of Guidelines for Research and Evaluation) instrument and the results by domain were:&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; summary=&quot;Table: AGREE Results by Domain&quot; cellpadding=&quot;5&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;AGREE Domain&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;AHA&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;ADA&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;AAP&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Scope and Purpose&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;100%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;85%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;63%&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Stakeholder Involvement&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;53%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;64%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;56%&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Rigor of Development&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;59%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;38%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;40%&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Clarity and Presentation&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;81%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;78%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;72%&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Applicability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;15%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;22%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;15%&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Editorial Independence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;100%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;0%&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;0%&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p&gt;These three guidelines have clear pediatric-focused recommendations that are not directly based on evidence-based outcome data but were generated by consensus expert opinion or extrapolated from adult data. The recommendations developed for this Best Evidence Statement (BESt) are primarily based on a combination of local consensus and recommendations from the AHA guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Table of Recommendation Strength&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Table of Recommendation Strength&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Strength&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&quot;Strongly recommended&quot;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is consensus that benefits clearly outweigh risks and burdens (or vice-versa for negative recommendations).&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&quot;Recommended&quot;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is consensus that benefits are closely balanced with risks and burdens.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No recommendation made&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is a lack of consensus to direct development of a recommendation.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;&lt;strong&gt;Dimensions&lt;/strong&gt;: In determining the strength of a recommendation, the development group makes a considered judgment in a consensus process that incorporates critically appraised evidence, clinical experience, and other dimensions as listed below.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;&#xD;&#xA;            &lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Grade of the Body of Evidence &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Safety/Harm &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Health benefit to the patients (direct benefit) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Burden to patient of adherence to recommendation (cost, hassle, discomfort, pain, motivation, ability to adhere, time) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Cost-effectiveness to healthcare system (balance of cost/savings of resources, staff time, and supplies based on published studies or onsite analysis) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Directness (the extent to which the body of evidence directly answers the clinical question [population/problem, intervention, comparison, outcome]) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Impact on morbidity/mortality or quality of life &lt;/li&gt;&#xD;&#xA;            &lt;/ol&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Reviewed against quality criteria by two independent reviewers&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The strength of the recommendation (strongly recommended, recommended, and no recommendation) and quality of the evidence (1a-5b) are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;It is recommended that diabetes patients be screened for dyslipidemia following the algorithm in the original guideline document (Local Consensus, 2010 [5]; Kavey et al., 2006 [5a]; Daniels, Greer, &amp;amp; Committee on Nutrition, 2008 [5b]; Silverstein et al., 2005 [5b]).&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Note&lt;/strong&gt;: Timing for the first screening is based on age (at least two years), family history for cardiovascular disease (negative history delays need for screening), and puberty (all patients screened not later than puberty regardless of family history) (Local Consensus, 2010 [5]; Kavey et al., 2006 [5a]; Daniels, Greer, &amp;amp; Committee on Nutrition, 2008 [5b]; Silverstein et al., 2005 [5b]).&lt;/p&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is recommended that patients with fasting low-density lipoprotein (LDL) levels greater than 100 mg/dL (milligrams per deciliter) be initially managed with a heart healthy diet, exercise, and monitoring of LDL levels (Local Consensus, 2010 [5]; Kavey et al., 2006 [5a]; Silverstein et al., 2005 [5b]). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is recommended that patients following a heart healthy diet with fasting LDL levels that persist for six months above 100 mg/dL be educated on the inclusion of plant sterols into their diet (Local Consensus, 2010 [5]; Robinson, 2009 [5a]; Law, 2000 [5a]; Daniels, Greer, &amp;amp; Committee on Nutrition, 2008 [5b]). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is recommended that patients who continue to have LDL levels &amp;gt;100 mg/dL after following a heart healthy diet and exercise for 12 months, and plant sterols for 6 months:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;If age &amp;ge;10 years: start on statins (males Tanner 2, females past menarche) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;If age &amp;lt;10 years: be considered for referral to cardiology, based on risk factors and family history (Local Consensus, 2010 [5]; Kavey et al., 2006 [5a]; Silverstein et al., 2005 [5b]). &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is recommended that patients with persistently elevated LDL levels be managed following the algorithm in the original guideline document (Daniels, Greer, &amp;amp; Committee on Nutrition, 2008 [5b]; Silverstein et al., 2005 [5b]).&#xD;&#xA;    &lt;p&gt;&lt;strong&gt;Note&lt;/strong&gt;: Referral to cardiology may be appropriate based on age, family history for cardiovascular disease and other risk factors (Local Consensus, 2010 [5]).&lt;/p&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Table of Evidence Levels&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Table of Evidence Levels&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Quality Level&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;1a&amp;dagger; or 1b&amp;dagger;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Systematic review, meta-analysis, or meta-synthesis of multiple studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;2a or 2b&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Best study design for domain&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;3a or 3b&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Fair study design for domain&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;4a or 4b&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Weak study design for domain&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;5&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Other: General review, expert opinion, case report, consensus report, or guideline&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&amp;dagger;a = good quality study; b = lesser quality study&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Table of Recommendation Strength&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Table of Recommendation Strength&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Strength&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&quot;Strongly recommended&quot;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is consensus that benefits clearly outweigh risks and burdens (or vice-versa for negative recommendations).&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&quot;Recommended&quot;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is consensus that benefits are closely balanced with risks and burdens.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No recommendation made&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;There is a lack of consensus to direct development of a recommendation.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;&lt;strong&gt;Dimensions&lt;/strong&gt;: In determining the strength of a recommendation, the development group makes a considered judgment in a consensus process that incorporates critically appraised evidence, clinical experience, and other dimensions as listed below.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;&#xD;&#xA;            &lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Grade of the Body of Evidence &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Safety/Harm &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Health benefit to the patients (direct benefit) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Burden to patient of adherence to recommendation (cost, hassle, discomfort, pain, motivation, ability to adhere, time) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Cost-effectiveness to healthcare system (balance of cost/savings of resources, staff time, and supplies based on published studies or onsite analysis) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Directness (the extent to which the body of evidence directly answers the clinical question [population/problem, intervention, comparison, outcome]) &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Impact on morbidity/mortality or quality of life &lt;/li&gt;&#xD;&#xA;            &lt;/ol&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A clinical algorithm is provided in the original guideline document for dyslipidemia management for diabetes patients.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="98" OrdBy="605" ID="425" Name="References Supporting the Recommendations" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008 Jul;122(1):198-208. [69 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18596007&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J, American Heart Association Expert Panel on Population and Prevention Science, American Heart Association Council on Cardiovascular Disease in the Young, American Heart Association Council on Epidemiology and Prevention, American Heart Association Council on Nutrition, Physical Activity and Metabolism, American Heart Association Council on High Blood Pressure Research, American Heart Association Council on Cardiovascular Nursing, American Heart Association Council on the Kidney in Heart Disease, Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology [trunc]. Circulation. 2006 Dec 12;114(24):2710-38. [401 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17130340&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Law M. Plant sterol and stanol margarines and health. BMJ. 2000 Mar 25;320(7238):861-4. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10731187&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Robinson MT. Nutrition evidence-based guidelines for treating hyperlipidemia in children with  type 1 diabetes: a case presentation. Diabetes Educ. 2009 May-Jun;35(3):408-19. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19349468&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005 Jan;28(1):186-212. [237 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15616254&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The three guidelines reviewed have clear pediatric-focused recommendations that are not directly based on evidence-based outcome data but were generated by consensus expert opinion or extrapolated from adult data. The recommendations developed for this Best Evidence Statement (BESt) are primarily based on a combination of local consensus and recommendations from the American Heart Association (AHA) guideline.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The American Heart Association and the American Diabetes Association emphasize the importance of early recognition of elevation of low-density lipoproteins (LDLs) in children with diabetes. Cardiovascular disease, cerebrovascular disease and peripheral vascular disease resulting from atherosclerosis are leading causes of morbidity and mortality among adults with type 1 diabetes and there is unequivocal evidence that atherosclerosis is well established in adolescence with dyslipidemia being the major risk factor. Early education regarding cardiovascular health and early intervention in children with LDL elevation is critical to improving long term outcomes. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Although plant sterols are not currently part of the dietary treatment recommendations from the American Diabetes Association in children, the American Heart Association's recommendations suggest plant sterols may be a useful adjunct to therapy. A review of randomized controlled trials of adult participants adding plant sterols to their diet reported a reduction in serum concentration of LDL cholesterol that would be expected to reduce the risk of heart disease by about 25% at an intake of 2 gm per day. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Side effects of plant sterols are indigestion, constipation and diarrhea. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pharmacotherapy with statins, such as atorvastatin, is Food and Drug Administration (FDA) approved in children over 10 years of age. Side effects with statin therapy include diarrhea, arthralgia, and nasopharyngitis. There is also discussion about a risk of elevated liver enzymes (0.2% to 2.3%). The recommendations address this risk with measurement of liver enzymes at baseline and then monitoring every 3 months after starting on statin therapy. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This Best Evidence Statement addresses only key points of care for the target population; it is not intended to be a comprehensive practice guideline. These recommendations result from review of literature and practices current at the time of their formulation. This Best Evidence Statement does not preclude using care modalities proven efficacious in studies published subsequent to the current revision of this document. This document is not intended to impose standards of care preventing selective variances from the recommendations to meet the specific and unique requirements of individual patients. Adherence to this Statement is voluntary. The clinician in light of the individual circumstances presented by the patient must make the ultimate judgment regarding the priority of any specific procedure.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Audit Criteria/Indicators" /><FieldValue Value="Clinical Algorithm" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Cincinnati Children's Hospital Medical Center. Best evidence statement (BESt). Screening and management of dyslipidemia in diabetic patients. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2010 Oct 27. 6 p.  [8 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2010 Oct 27" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Cincinnati Children's Hospital Medical Center - Hospital/Medical Center" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Cincinnati Children's Hospital Medical Center&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Group/Team Leader&lt;/em&gt;: Deborah Elder, MD, Endocrinology&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Other Group/Team Members&lt;/em&gt;: Mandi Cafasso, RN, CNP, Endocrinology; Allison Deisinger, RD, LD, CDE, Endocrinology; Kristen Wetherill, RD, LD, CDE, Endocrinology; Nana Jones, MD, Endocrinology; Nancy Morwessel, RN, CNP, Endocrinology&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Clinical Effectiveness Support Personnel&lt;/em&gt;: Anjali Basu, MS, Associate Outcomes Manager; Eloise Clark, MPH, MBA, Guidelines Program Administrator, Evidence Facilitator; Danette Stanko-Lopp, MA, MPH, Epidemiologist; Karen Vonderhaar, MS, RN, Guidelines Program Administrator, Methodologist&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available from the &lt;a href=&quot;http://www.cincinnatichildrens.org/WorkArea/linkit.aspx?LinkIdentifier=id&amp;amp;ItemID=88044&amp;amp;libID=87732&quot; title=&quot;CCHMC Web site&quot;&gt;Cincinnati Children's Hospital Medical Center&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: For information regarding the full-text guideline, print copies, or evidence-based practice support services contact the Cincinnati Children's Hospital Medical Center Health James M. Anderson Center for Health Systems Excellence at &lt;a href=&quot;mailto:EBDMInfo@cchmc.org&quot;&gt;EBDMInfo@cchmc.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Judging the strength of a recommendation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2008 Jan. 1 p. Available from the &lt;a href=&quot;http://www.cincinnatichildrens.org/assets/0/78/1067/2709/2777/2793/9200/d7344329-03d0-45f3-b6ca-02c746a472ec.pdf&quot; title=&quot;CCHMC Web site&quot;&gt;Cincinnati Children's Hospital Medical Center&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Grading a body of evidence to answer a clinical question. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 1 p. Available from the &lt;a href=&quot;http://www.cincinnatichildrens.org/assets/0/78/1067/2709/2777/2793/9200/bd6f4eea-825c-49c3-a0e5-3e66c54dc066.pdf&quot; title=&quot;CCHMC Web site&quot;&gt;Cincinnati Children's Hospital Medical Center&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Table of evidence levels. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2008 Feb 29. 1 p. Available from the &lt;a href=&quot;http://www.cincinnatichildrens.org/assets/0/78/1067/2709/2777/2793/9200/5ce396bf-fdcb-4c65-a9f2-1b9888d4fc7e.pdf&quot; title=&quot;CCHMC Web site&quot;&gt;Cincinnati Children's Hospital Medical Center&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Print copies: For information regarding the full-text guideline, print copies, or evidence-based practice support services contact the Cincinnati Children's Hospital Medical Center Health James M. Anderson Center for Health Systems Excellence at &lt;a href=&quot;mailto:EBDMInfo@cchmc.org&quot;&gt;EBDMInfo@cchmc.org&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In addition, proposed audit measures are listed in the &lt;a href=&quot;http://www.cincinnatichildrens.org/WorkArea/linkit.aspx?LinkIdentifier=id&amp;amp;ItemID=88044&amp;amp;libID=87732&quot; title=&quot;CCHMC Web site&quot;&gt;original guideline document&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on March 16, 2011. This summary was updated by ECRI Institute on June 27, 2011 following the U.S. Food and Drug Administration advisory on Zocor (simvastatin). This summary was updated by ECRI Institute on April 13, 2012 following the U.S. Food and Drug Administration advisories on Statin Drugs and Statins and HIV or Hepatitis C drugs.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original full-text guideline, which is subject to the following copyright restrictions:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Copies of this &lt;a href=&quot;http://www.cincinnatichildrens.org/svc/alpha/h/health-policy/best.htm&quot; title=&quot;CCHMC Web site&quot;&gt;Cincinnati Children's Hospital Medical Center (CCHMC)&lt;/a&gt; Best Evidence Statement (BESt) are available online and may be distributed by any organization for the global purpose of improving child health outcomes. Examples of approved uses of the BESt include the following:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Copies may be provided to anyone involved in the organization's process for developing and implementing evidence based care; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hyperlinks to the CCHMC website may be placed on the organization's website; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The BESt may be adopted or adapted for use within the organization, provided that CCHMC receives appropriate attribution on all written or electronic documents; and &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Copies may be provided to patients and the clinicians who manage their care. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Notification of CCHMC at &lt;a href=&quot;mailto:EBDMInfo@cchmc.org&quot;&gt;EBDMInfo@cchmc.org&lt;/a&gt; for any BESt adopted, adapted, implemented or hyperlinked by the by the organization is appreciated.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
